In Brief This Week: EKF Diagnostics, Selah Genomics, DiaSpect; NeoGenomics; Epigenomics, BioChain; BioDatomics; PerkinElmer; Quest, Summit Health; Genalice | GenomeWeb

NEW YORK (GenomeWeb News) – EKF Diagnostics this week said it completed its acquisitions of Selah Genomics and DiaSpect Medical. When the deals were announced last month, EKF said the Selah acquisition comprises an initial consideration of $35.6 million through the issue of new EKF shares and an additional deferred consideration of up to $35 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.